Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients.

Acanfora, Domenico; Ciccone, Marco Matteo; Scicchitano, Pietro; Acanfora, Chiara; Casucci, Gerardo

Acanfora, Domenico; Ciccone, Marco Matteo; Scicchitano, Pietro; Acanfora, Chiara; Casucci, Gerardo.

Acanfora D; Unit of Internal Medicine, San Francesco Hospital, Viale Europa 21, 82037 Telese Terme (BN), Italy.
Ciccone MM; Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation, University of Bari, School of Medicine, Bari, Italy.
Scicchitano P; Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation, University of Bari, School of Medicine, Bari, Italy.
Acanfora C; Cardiology Unit, Hospital 'F. Perinei' ASL BA, Altamura, Bari, Italy.
Casucci G; Unit of Internal Medicine, San Francesco Hospital, Viale Europa 21, 82037 Telese Terme (BN), Italy.

Eur Heart J Cardiovasc Pharmacother ; 6(3): 135-136, 2020 07 01.

Article in English | MEDLINE | ID: covidwho-47992

Subject(s)

Plaque, Atherosclerotic; Severe acute respiratory syndrome-related coronavirus; Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Apolipoproteins; Betacoronavirus; Biphenyl Compounds; COVID-19; Coronavirus Infections; Drug Combinations; Humans; Inflammation; Mice; Neprilysin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tetrazoles; Valsartan

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severe acute respiratory syndrome-related coronavirus / Plaque, Atherosclerotic Limits: Animals / Humans Language: English Journal: Eur Heart J Cardiovasc Pharmacother Year: 2020 Document Type: Article Affiliation country: Ehjcvp

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google